Media-OutReach Newswire Inhibiting Inflammatory Responses, Three Scientists Awarded 2020 Tang Prize in Biopharmaceutical Science
Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies 2.